Factors influencing intention to participate in breast cancer screening. An exploratory structural model.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
15
09
2021
accepted:
26
12
2022
entrez:
3
2
2023
pubmed:
4
2
2023
medline:
8
2
2023
Statut:
epublish
Résumé
The paper has two objectives. The first one examines whether informing women about the benefits and adverse effects of breast cancer screening could have an effect on three variables: their knowledge, the importance women attach to the future consequences of their current decisions (time perspective), and the degree to which women are worried about developing breast cancer (worry). The second one examines whether these three variables affect their intention to participate in the screening, either directly or indirectly through their feeling of regret if they do not attend the screening (anticipated regret); through their values and the support they receive in making their decisions (decisional conflict); and, through the perceived acceptability and benefits of the screening programme (attitude). Partial least squares-structural equation modelling (PLS-SEM) is used to analyse both objectives and to differentiate between direct, indirect, and moderating effects, due to the incorporation in the model of the three mediating variables (anticipated regret, decisional conflict, and attitude) and a moderating variable (educational level). Information affects knowledge (objective variable), but not the behavioural variables (time perspective and worry). On the other hand, the level of knowledge has no direct or indirect effect on intention, but behavioural variables do affect it through the mediating variables. The variables of the planned behaviour theory are relevant to understand women's decisions and to be able to take appropriate health policy measures. Doing so, the processes of personalised screening would improve, or there would be the incorporation of shared decision-making in this context; these being demands associated with the most recent goals achieved in health programmes in many countries.
Identifiants
pubmed: 36735750
doi: 10.1371/journal.pone.0281454
pii: PONE-D-21-29869
pmc: PMC9897558
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0281454Informations de copyright
Copyright: © 2023 López-Panisello et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Patient Educ Couns. 2006 Apr;61(1):56-64
pubmed: 16533677
J Natl Cancer Inst. 2021 Nov 2;113(11):1523-1530
pubmed: 33871631
Antimicrob Agents Chemother. 2014 Dec;58(12):7250-7
pubmed: 25246403
BMJ. 2010 Oct 26;341:c5370
pubmed: 20978060
Patient Educ Couns. 2010 Oct;81(1):63-72
pubmed: 20149953
Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):501-10
pubmed: 15066912
Med Decis Making. 2016 Aug;36(6):777-90
pubmed: 26975351
Arch Intern Med. 2007 Oct 22;167(19):2039-46
pubmed: 17954796
Women Health. 2009 Mar-May;49(2-3):101-18
pubmed: 19533505
Health Expect. 2012 Jun;15(2):176-86
pubmed: 21501350
Breast Cancer Res. 2005;7(5):228-9
pubmed: 16168144
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Women Health. 2013;53(8):761-76
pubmed: 24215271
Patient Educ Couns. 2006 Nov;63(3):367-79
pubmed: 16875796
Soc Sci Med. 2015 Oct;142:118-27
pubmed: 26301484
BMJ Open. 2017 Oct 6;7(10):e016246
pubmed: 28988168
PLoS One. 2019 Mar 26;14(3):e0214057
pubmed: 30913217
Prev Med. 1997 Jul-Aug;26(4):473-82
pubmed: 9245669
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Prev Med. 2006 Jun;42(6):401-8
pubmed: 16626796
Lancet. 2015 Apr 25;385(9978):1642-52
pubmed: 25701273
Dtsch Arztebl Int. 2015 Jan 30;112(5):61-8
pubmed: 25686383
Trials. 2017 Sep 12;18(1):426
pubmed: 28899412
J Womens Health (Larchmt). 2015 Dec;24(12):1013-20
pubmed: 26360918
Health Psychol. 2011 Nov;30(6):702-9
pubmed: 21639637
Br J Cancer. 2013 Jun 11;108(11):2205-40
pubmed: 23744281
Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):96-102
pubmed: 12582018
Gac Sanit. 2021 May-Jun;35(3):243-249
pubmed: 32173050
Br J Soc Psychol. 2009 Jun;48(Pt 2):221-36
pubmed: 18793492
Cancer Med. 2015 Dec;4(12):1923-32
pubmed: 26377150
Prev Med. 2009 May;48(5):411-4
pubmed: 18996144